Diagnostic utility of circulating plasma microRNA-101a in severity of coronary heart disease
ConclusionsCirculating miR-101a may be considered as a novel biomarker for evaluating the presence and severity of CHD.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Cardiology | Cholesterol | Coronary Heart Disease | General Medicine | Heart | Heart Disease | Ireland Health | Science | Smokers